AR and prostate cancer: In the prostate cancer cell line 22Rv1 that expresses the full-length AR mRNA and a truncated AR splice variant, siRNA-mediated knockdown of both full-length and truncated variant, but not knockdown of full-length alone, effectively suppresses androgen-independent cell proliferation and initiates cell apoptosis [168].